
YES1 Gene - GeneCards | YES Protein | YES Antibody
Mar 30, 2025 · YES1 (YES Proto-Oncogene 1, Src Family Tyrosine Kinase) is a Protein Coding gene. Diseases associated with YES1 include Sarcoma and Colorectal Cancer. Among its …
Tyrosine-protein kinase Yes - Wikipedia
Tyrosine-protein kinase Yes is a non-receptor tyrosine kinase that in humans is encoded by the YES1 gene. [5] [6] This gene is the cellular homolog of the Yamaguchi sarcoma virus …
YES1: A Novel Therapeutic Target and Biomarker in Cancer
Sep 6, 2022 · YES1 is a nonreceptor tyrosine kinase that belongs to the SRC family of kinases (SFK) and controls multiple cancer signaling pathways. YES1 is amplified and overexpressed …
A renaissance for YES in cancer | Oncogene - Nature
Oct 17, 2023 · Amplification of YES1 or increased expression/activity of YES has recently emerged as a mechanism of acquired resistance to targeted therapies and chemotherapeutic …
YES1 Is a Targetable Oncogene in Cancers Harboring
Nov 15, 2019 · We proved the oncogenic activity of YES1, displayed the YES1 gene amplification in clinical, generated an inhibitor that was highly selective against SFK and especially against …
Emerging Roles of YES1 in Cancer: The Putative Target in Drug ...
YES1 plays a pivotal role in promoting cell proliferation, survival, and invasiveness during tumor development. Recent findings indicate that YES1 expression and activation are associated …
YES1 YES proto-oncogene 1, Src family tyrosine kinase [ (human)]
YES1 genetic depletion by CRISPR/Cas9 technology significantly reduced tumor growth and metastasis. YES1 plays an important role in the emergence of resistance to HER2-targeted …
YES1 YES proto-oncogene 1, Src family tyrosine kinase [Homo …
Feb 4, 2024 · YES1 is essential for NSCLC carcinogenesis. YES1 overexpression induced metastatic spread in preclinical in vivo models. YES1 genetic depletion by CRISPR/Cas9 …
YES1 Drives Lung Cancer Growth and Progression and Predicts
Oct 1, 2019 · Measurements and Main Results: We demonstrated that YES1 is essential for NSCLC carcinogenesis. Furthermore, YES1 overexpression induced metastatic spread in …
SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary …
We report response to SRC family kinase (SFK) inhibition in a patient whose lung cancer exhibited YES1 amplification, without any well-established primary driver alteration, suggesting …